Home›Signals›Short Interest
■

Short Interest

Heavily shorted biotech stocks and squeeze potential

50 Active Signals
ZBIOZenas BioPharma, Inc.Biotech / Pharma
Short interest: 30.79% of float, squeeze risk: HIGH SI: 30.79%
B
70/100
UPCUniverse Pharmaceuticals Inc. Class ABiotech / Pharma
Short interest: 48.73% of float, squeeze risk: MODERATE SI: 48.73%
D
46/100
TYRATyra BiosciencesPrecision Medicine
Short interest: 38.61% of float, squeeze risk: HIGH SI: 38.61%
C
63/100
TNGXTango Therapeutics, Inc.Biotech / Pharma
Short interest: 60.36% of float, squeeze risk: HIGH SI: 60.36%
C
53/100
SRPTSarepta TherapeuticsGene Therapy
Short interest: 30.31% of float, squeeze risk: HIGH SI: 30.31%
A
86/100
SNSESensei Biotherapeutics, Inc.Biotech / Pharma
Short interest: 75.8% of float, squeeze risk: HIGH SI: 75.8%
C
50/100
SLSSELLAS Life Sciences Group, Inc.Biotech / Pharma
Short interest: 34.18% of float, squeeze risk: MODERATE SI: 34.18%
D
39/100
SLDBSolid BiosciencesGene Therapy
Short interest: 34.0% of float, squeeze risk: MODERATE SI: 34%
D
48/100
SIONSionna Therapeutics, Inc.Biotech / Pharma
Short interest: 32.88% of float, squeeze risk: HIGH SI: 32.88%
F
33/100
RLMDRelmada Therapeutics, Inc.Biotech / Pharma
Short interest: 137.95% of float, squeeze risk: MODERATE SI: 137.95%
C
52/100
RLAYRelay TherapeuticsPrecision Oncology
Short interest: 31.64% of float, squeeze risk: HIGH SI: 31.64%
C
50/100
PRMEPrime Medicine, Inc.Biotech / Pharma
Short interest: 31.94% of float, squeeze risk: HIGH SI: 31.94%
C
52/100
NVAXNovavax IncVaccines
Short interest: 32.38% of float, squeeze risk: HIGH SI: 32.38%
F
30/100
NTLAIntellia TherapeuticsGene Editing
Short interest: 36.69% of float, squeeze risk: HIGH SI: 36.69%
B
73/100
NKTRNektar TherapeuticsImmunology
Short interest: 32.36% of float, squeeze risk: MODERATE SI: 32.36%
C
61/100
LXEOLexeo Therapeutics, Inc.Biotech / Pharma
Short interest: 33.95% of float, squeeze risk: HIGH SI: 33.95%
C
52/100
LENZLENZ Therapeutics, Inc.Biotech / Pharma
Short interest: 56.45% of float, squeeze risk: HIGH SI: 56.45%
F
34/100
KPTIKaryopharm TherapeuticsOncology
Short interest: 44.8% of float, squeeze risk: HIGH SI: 44.8%
A
87/100
IBRXImmunityBio, Inc.Biotech / Pharma
Short interest: 33.46% of float, squeeze risk: HIGH SI: 33.46%
C
64/100
GLUEMonte Rosa TherapeuticsProtein Degradation
Short interest: 35.2% of float, squeeze risk: HIGH SI: 35.2%
D
38/100
CELCCelcuity IncOncology
Short interest: 40.91% of float, squeeze risk: HIGH SI: 40.91%
C
59/100
CCCCC4 Therapeutics, Inc.Biotech / Pharma
Short interest: 31.39% of float, squeeze risk: HIGH SI: 31.39%
D
46/100
CATXPerspective TherapeuticsOncology
Short interest: 30.57% of float, squeeze risk: HIGH SI: 30.57%
C
62/100
CAPRCapricor Therapeutics, Inc.Biotech / Pharma
Short interest: 30.36% of float, squeeze risk: HIGH SI: 30.36%
F
25/100
BJDXBluejay Diagnostics, Inc.Diagnostics
Short interest: 53.9% of float, squeeze risk: MODERATE SI: 53.9%
F
29/100
AVTXAvalo Therapeutics, Inc.Biotech / Pharma
Short interest: 30.63% of float, squeeze risk: MODERATE SI: 30.63%
F
31/100
AUTLAutolus TherapeuticsCell Therapy
Short interest: 36.85% of float, squeeze risk: HIGH SI: 36.85%
D
35/100
ASMBAssembly BiosciencesInfectious Disease
Short interest: 32.02% of float, squeeze risk: HIGH SI: 32.02%
F
23/100
ADILAdial Pharmaceuticals, IncBiotech / Pharma
Short interest: 33.78% of float, squeeze risk: MODERATE SI: 33.78%
F
22/100
ACXPAcurx Pharmaceuticals, Inc.Biotech / Pharma
Short interest: 38.36% of float, squeeze risk: MODERATE SI: 38.36%
D
43/100
ABEOAbeona Therapeutics Inc.Biotech / Pharma
Short interest: 32.11% of float, squeeze risk: HIGH SI: 32.11%
C
51/100
SPRYSpruce BiosciencesEndocrinology
Short interest: 51.2% of float, squeeze risk: HIGH SI: 51.2%
F
28/100
MNPRMonopar Therapeutics Inc.Biotech / Pharma
Short interest: 36.8% of float, squeeze risk: HIGH SI: 36.8%
F
28/100
MISTMilestone MedicalOphthalmology IOP
Short interest: 89.56% of float, squeeze risk: HIGH SI: 89.56%
F
31/100
KALVKalVista Pharmaceuticals, Inc.Biotech / Pharma
Short interest: 31.57% of float, squeeze risk: MODERATE SI: 31.57%
D
41/100
INBXInhibrx IncOncology / Rare
Short interest: 43.88% of float, squeeze risk: HIGH SI: 43.88%
B
77/100
FDMT4D Molecular Therapeutics, Inc.Biotech / Pharma
Short interest: 34.26% of float, squeeze risk: HIGH SI: 34.26%
B
67/100
CMPXCompass Therapeutics, Inc.Biotech / Pharma
Short interest: 30.27% of float, squeeze risk: HIGH SI: 30.27%
B
75/100
CLDICalidi Biotherapeutics, Inc.Biotech / Pharma
Short interest: 39.91% of float, squeeze risk: MODERATE SI: 39.91%
D
49/100
ZBIOZenas BioPharma, Inc.Biotech / Pharma
Short interest: 30.79% of float, squeeze risk: HIGH SI: 30.79%
B
70/100
UPCUniverse Pharmaceuticals Inc. Class ABiotech / Pharma
Short interest: 48.73% of float, squeeze risk: MODERATE SI: 48.73%
D
46/100
TYRATyra BiosciencesPrecision Medicine
Short interest: 38.61% of float, squeeze risk: HIGH SI: 38.61%
C
63/100
TNGXTango Therapeutics, Inc.Biotech / Pharma
Short interest: 60.36% of float, squeeze risk: HIGH SI: 60.36%
C
53/100
SRPTSarepta TherapeuticsGene Therapy
Short interest: 30.31% of float, squeeze risk: HIGH SI: 30.31%
A
86/100
SNSESensei Biotherapeutics, Inc.Biotech / Pharma
Short interest: 75.8% of float, squeeze risk: HIGH SI: 75.8%
C
50/100
SLSSELLAS Life Sciences Group, Inc.Biotech / Pharma
Short interest: 34.18% of float, squeeze risk: MODERATE SI: 34.18%
D
39/100
SLDBSolid BiosciencesGene Therapy
Short interest: 34.0% of float, squeeze risk: MODERATE SI: 34%
D
48/100
SIONSionna Therapeutics, Inc.Biotech / Pharma
Short interest: 32.88% of float, squeeze risk: HIGH SI: 32.88%
F
33/100
RLMDRelmada Therapeutics, Inc.Biotech / Pharma
Short interest: 137.95% of float, squeeze risk: MODERATE SI: 137.95%
C
52/100
RLAYRelay TherapeuticsPrecision Oncology
Short interest: 31.64% of float, squeeze risk: HIGH SI: 31.64%
C
50/100
Not financial advice. BiotechSign data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.